PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY | MicrobiomeTrials← Back to trialsNCT05098665
PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-01-01Est. Completion: 2027-12
Enrollment target: 320 participants Locations- Richmond Research Institute, London, London, United Kingdom
Other microbiome trials you might be interested in
Kawasaki DiseaseCoronary Artery Abnormalities
The goal of this observational study is to learn about the safety and effects of atorvastatin in treatment of Chinese Ka…
Shanghai, ChinaEst. completion Aug 31, 2027
Cardiac Amyloidosis
Cardiac amyloidosis (CA) is an infiltrative disease characterized by deposits of amyloid proteins of genetic or acquired…
Dijon, FranceEst. completion Jul 2028